BUY NOW For Sale 70%!
buy viagra

Cipro dose for travelers diarrhea

1. Adachi, J. A., C. D. Ericsson, Z. D. Jiang, M. W. DuPont, F. Martinez-Sandoval, C. Knirsch, and H. L. DuPont. 2003. Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. Clin. Infect. Dis. 37:1165-1171. [PubMed]

2. Adachi, J. A., J. J. Mathewson, Z. D. Jiang, C. D. Ericsson, and H. L. DuPont. 2002. Enteric pathogens in Mexican sauces of popular restaurants in Guadalajara, Mexico, and Houston, Texas. Ann. Intern. Med. 136:884-887. [PubMed]

3. Adachi, J. A., Z. D. Jiang, J. J. Mathewson, M. P. Verenkar, S. Thompson, F. Martinez-Sandoval, R. Steffen, C. D. Ericsson, and H. L. DuPont. 2001. Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin. Infect. Dis. 32:1706-1709. [PubMed]

4. Alcantara, C. S., C. H. Yang, T. S. Steiner, L. J. Barrett, A. A. Lima, C. L. Chappell, P. C. Okhuysen, A. C. White, Jr., and R. L. Guerrant. 2003. Interleukin-8, tumor necrosis factor-α, and lactoferrin in immunocompetent hosts with experimental and Brazilian children with acquired cryptosporidiosis. Am. J. Trop. Med. Hyg. 68:325-328. [PubMed]

5. Ansdell, V. E., and C. D. Ericsson. 1999. Prevention and empiric treatment of traveler's diarrhea. Med. Clin. N. Am. 83:945-973. [PubMed]

6. Ashley, D. V., C. Walters, C. Dockery-Brown, A. McNab, and D. E. Ashley. 2004. Interventions to prevent and control food-borne diseases associated with a reduction in traveler's diarrhea in tourists to Jamaica. J. Travel Med. 11:364-367. [PubMed]

7. Baqar, S., A. L. Bourgeois, P. J. Schultheiss, R. I. Walker, D. M. Rollins, R. L. Haberberger, and O. R. Pavlovskis. 1995. Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates. Vaccine 13:22-28. [PubMed]

8. Barua, D., and A. S. Paguio. 1977. ABO blood groups and cholera. Ann. Hum. Biol. 4:489-492. [PubMed]

9. Beecham, H. J., C. I. Lebron, and P. Echeverria. 1997. Short report: impact of traveler's diarrhea on United States troops deployed to Thailand. Am. J. Trop. Med. Hyg. 57:699-701. [PubMed]

10. Black, R. E. 1990. Epidemiology of travelers' diarrhea and relative importance of various pathogens. Rev. Infect. Dis. 12:S73-S79. [PubMed]

11. Blake, P. A., M. L. Rosenberg, J. Florencia, J. B. Costa, L. do Prado Quintino, and E. J. Gangarosa. 1977. Cholera in Portugal, 1974. II. Transmission by bottled mineral water. Am. J. Epidemiol. 105:344-348. [PubMed]

12. Bowie, M. D., I. D. Hill, and M. D. Mann. 1995. Loperamide for treatment of acute diarrhoea in infants and young children. A double-blind placebo-controlled trial. S. Afr. Med. J. 85:885-887. [PubMed]

13. Brodsky, R. E., H. C. Spencer, and M. G. Schuttz. 1974. Giardiasis in American travelers to the Soviet Union. J. Infect. Dis. 130:319-323. [PubMed]

14. Cartwright, R. 2004. The role of hygiene and public health programs in reducing the incidence of travelers' diarrhea. Comment on consensus paper by Steffen et al. J. Travel Med. 11:189-190. [PubMed]

15. Casburn-Jones, A. C., and M. J. G. Farthing. 2004. Traveler's diarrhea. J. Gastroenterol. Hepatol. 19:610-618. [PubMed]

16. Centers for Disease Control and Prevention. 2003. Norovirus activity 2002—USA. Morb. Mortal. Wkly. Rep. 52:41-45. [PubMed]

17. Chang, T.-W. 1978. Traveler's diarrhea. Ann. Intern. Med. 89:428-429. (Letter.) [PubMed]

18. CHOICE Study Group. 2001. Multicenter, randomized, double-blind clinical trial to evaluate the efficacy and safety of a reduced osmolarity oral rehydration salts solution in children with acute watery diarrhea. Pediatrics 107:613-618. [PubMed]

19. Clements, J. D., and R. A. Finkelstein. 1978. Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin. Infect. Immun. 21:1036-1039. [PMC free article] [PubMed]

20. Cobelens, R. G. J., A. Leentvaar-Kuijpers, J. Kleinjnen, and R. A. Coutinho. 1998. Incidence and risk factors of diarrhoea in Dutch travelers: consequences for priorities in pre-travel health advice. Trop. Med. Int. Health 11:896-903. [PubMed]

21. Cohen, D., S. Ashkenazi, M. Green, Y. Lerman, R. Slepon, G. Robin, N. Orr, D. N. Taylor, J. C. Sadoff, C. Chu, J. Shiloach, R. Schneerson, and J. B. Robbins. 1996. Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers. Infect. Immun. 64:4074-4077. [PMC free article] [PubMed]

22. Cohen, D., S. Ashkenazi, M. S. Green, M. Gdalevich, G. Robin, R. Slepon, M. Yavzori, N. Orr, C. Block, I. Ashkenazi, J. Shemer, D. N. Taylor, T. L. Hale, J. C. Sadoff, D. Pavliakova, R. Schneerson, and J. B. Robbins. 1997. Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. Lancet 349:155-159. [PubMed]

23. Cornick, N. A., M. Silva, and S. L. Gorbach. 1990. In vitro activity of bismuth subsalicylate. Rev. Infect. Dis. 12:S9-S10. [PubMed]

24. Coster, T. S., C. W. Hoge, L. L. VanDe Verg, A. B. Hartman, E. V. Oaks, M. M. Venkatesan, D. Cohen, G. Robin, A. Fontaine-Thompson, P. J. Sansonetti, and T. L. Hale. 1999. Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602. Infect. Immun. 67:3437-3443. [PMC free article] [PubMed]

25. Czeczulin, J. R., S. Balepur, S. Hicks, A. Phillips, R. Hall, M. H. Kothary, F. Navarro-Garcia, and J. P. Nataro. 1997. Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli. Infect. Immun. 65:4135-4145. [PMC free article] [PubMed]

26. Czeczulin, J. R., T. S. Whittam, I. R. Henderson, F. Navarro-Garcia, and J. P. Nataro. 1999. Phylogenetic analysis of enteroaggregative and diffusely adherent Escherichia coli. Infect. Immun. 67:2692-2699. [PMC free article] [PubMed]

27. de Bruyn, G., S. Hahn, and A. Borwick. 2000. Antibiotic treatment for travellers' diarrhoea. Cochrane Database Syst. Rev. 3:CD002242. [PubMed]

28. Descombe, J. J., D. Dubourg, M. Picard, and E. Palazzini. 1994. Pharmacokinetic study of rifaximin after oral administration in healthy volunteers. Int. J. Clin. Pharmacol. Res. 14:51-56. [PubMed]

29. DuPont, A. W., and H. L. DuPont. 2006. Travelers' diarrhea: modern concepts and new developments. Curr. Treat. Options Gastroenterol. 9:13-21. [PubMed]

30. DuPont, H. L. 1987. Bismuth subsalicylate in the treatment and prevention of diarrheal disease. Drug Intell. Clin. Pharm. 21:687-693. [PubMed]

31. DuPont, H. L., and C. D. Ericsson. 1993. Prevention and treatment of traveler's diarrhea. N. Engl. J. Med. 328:1821-1827. [PubMed]

32. DuPont, H. L., and E. G. Capsuto. 1996. Persistent diarrhea in travelers. Clin. Infect. Dis. 22:124-128. [PubMed]

33. DuPont, H. L., and R. B. Hornick. 1973. Adverse effects of Lomotil therapy in shigellosis. JAMA 226:1525-1528. [PubMed]

34. DuPont, H. L., C. D. Ericsson, J. J. Mathewson, and M. W. DuPont. 1992. Five versus three days of ofloxacin therapy for traveler's diarrhea: a placebo-controlled study. Antimicrob. Agents Chemother. 36:87-91. [PMC free article] [PubMed]

35. DuPont, H. L., C. D. Ericsson, J. J. Mathewson, E. Palazzini, M. W. DuPont, Z. D. Jiang, A. Mosavi, and F. J. de la Cabada. 1998. Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea. Digestion 59:708-714. [PubMed]

36. DuPont, H. L., C. D. Ericsson, P. C. Johnson, J. A. Bitsura, M. W. Dupont, and F. J. de la Cabada. 1987. Prevention of traveler's diarrhea by the tablet formulation of bismuth subsalicylate. JAMA 257:1347-1350. [PubMed]

37. Dupont, H. L., E. Galindo, D. G. Evans, F. J. Cabada, P. Sullivan, and D. J. Evans, Jr. 1983. Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole and trimethoprim alone. Gastroenterology 84:75-80. [PubMed]

38. DuPont, H. L., J. Flores Sanchez, C. D. Ericsson, J. Mendiola Gomez, M. W. DuPont, A. Cruz Luna, and J. J. Mattewson. 1990. Comparative efficacy of loperamide hydrochloride and bismuth subsalicylate in the management of acute diarrhea. Am. J. Med. 88:15S-19S. [PubMed]

39. DuPont, H. L., P. Sullivan, L. K. Pickering, G. Haynes, and P. B. Ackerman. 1977. Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican university. Gastroenterology 73:715-718. [PubMed]

40. DuPont, H. L., R. R. Reves, E. Galindo, P. S. Sullivan, L. V. Wood, and J. G. Mendiola. 1982. Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone. N. Engl. J. Med. 307:841-844. [PubMed]

41. DuPont, H. L., Z. D. Jiang, C. D. Ericsson, J. A. Adachi, J. J. Mathewson, M. W. DuPont, E. Palazzini, L. M. Riopel, D. Ashley, and F. Martinez-Sandoval. 2001. Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial. Clin. Infect. Dis. 33:1807-1815. [PubMed]

42. DuPont, H. L., Z. D. Jiang, P. C. Okhuysen, C. D. Ericsson, F. J. de la Cabada, S. Ke, M. W. DuPont, and F. Martinez-Sandoval. 2005. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann. Intern. Med. 142:805-812. [PubMed]

43. DuPont, H. L., Z. D. Jiang, P. C. Okhuysen, C. D. Ericsson, F. J. de la Cabada, S. Ke, M. W. DuPont, and F. Martinez-Sandoval. 2005. Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximin. Clin. Infect. Dis. 41:S571-S576. [PubMed]

44. Echeverria, P., N. R. Blacklow, L. B. Sanford, and G. G. Cukor. 1981. Travelers' diarrhea among American Peace Corps volunteers in rural Thailand. J. Infect. Dis. 143:767-771. [PubMed]

45. Ericsson, C. D. 1998. Traveler's diarrhea: epidemiology, prevention, and self-treatment. Infect. Dis. Clin. N. Am. 12:285-303. [PubMed]

46. Ericsson, C. D., C. Tannenbaum, and T. T. Charles. 1990. Antisecretory and anti-inflammatory properties of bismuth subsalicylate. Rev. Infect. Dis. 12:S16-S20. [PubMed]

47. Ericsson, C. D., H. L. DuPont, and J. J. Mathewson. 1995. Epidemiologic observations on diarrhea developing in U.S. and Mexican students living in Guadalajara, Mexico. J. Travel Med. 2:6-10. [PubMed]

48. Ericsson, C. D., H. L. Dupont, and J. J. Mathewson. 1997. Single dose ofloxacin plus loperamide compared with single dose or three days of ofloxacin in the treatment of traveler's diarrhea. J. Travel Med. 4:3-7. [PubMed]

49. Ericsson, C. D., H. L. DuPont, J. J. Mathewson, M. S. West, P. C. Johnson, and J. A. Bitsura. 1990. Treatment of travelers' diarrhea with sulfamethoxazole and trimethoprim and loperamide. JAMA 263:257-261. [PubMed]

50. Ericsson, C. D., L. K. Pickering, P. Sullivan, and H. L. DuPont. 1980. The role of location of food consumption in the prevention of travelers' diarrhea in Mexico. Gastroenterology 79:812-816. [PubMed]

51. Ericsson, C. D., P. C. Johnson, H. L. Dupont, D. R. Morgan, J. A. Bitsura, and F. J. de la Cabada. 1987. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial. Ann. Intern. Med. 106:216-220. [PubMed]

52. Eslava, C., F. Navarro-Garcia, J. R. Czeczulin, I. R. Henderson, A. Cravioto, and J. P. Nataro. 1998. Pet, an autotransporter enterotoxin from enteroaggregative Escherichia coli. Infect. Immun. 66:3155-3163. [PMC free article] [PubMed]

53. Evans, M. R., C. D. Ribeiro, and R. L. Salmon. 2003. Hazards of healthy living: bottled water and salad vegetables as risk factors for Campylobacter infection. Emerg. Infect. Dis. 9:1219-1225. [PMC free article] [PubMed]

54. Evans, M. R., D. Shickle, and M. Z. Morgan. 2001. Travel illness in British package holiday tourists: prospective cohort study. J. Infect. 43:140-147. [PubMed]

55. Farris, R. K., E. J. Tapper, D. W. Powell, and S. M. Morris. 1976. Effect of aspirin on normal and cholera toxin-stimulated intestinal electrolyte transport. J. Clin. Investig. 57:916-924. [PMC free article] [PubMed]

56. Farthing, M. J. 2000. Enterotoxins and the enteric nervous system—a fatal attraction. Int. J. Med. Microbiol. 290:491-496. [PubMed]

57. Feldman, M. 1984. Southwestern internal medicine conference: traveler's diarrhea. Am. J. Med. Sci. 288:136-148. [PubMed]

58. Field, M., L. H. Graf, W. J. Laird, and P. L. Smith. 1978. Heat-stable enterotoxin of Escherichia coli: in vitro effects on guanylate cyclase activity, cyclic GMP concentration, and ion transport in small intestine. Proc. Natl. Acad. Sci. USA 75:2800-2804. [PMC free article] [PubMed]

59. Finck, A. D., and R. L. Katz. 1972. Prevention of cholera-induced intestinal secretion in the cat by aspirin. Nature 238:273-274. [PubMed]

60. Gaastra, W., and A. M. Svennerholm. 1996. Colonization factors of human enterotoxigenic Escherichia coli (ETEC). Trends Microbiol. 4:444-452. [PubMed]

61. Giannella, R. A., S. A. Broitman, and N. Zamchek. 1973. Influence of gastric acidity on bacterial and parasitic enteric diseases. Ann. Intern. Med. 78:271-276. [PubMed]

62. Gillis, J. C., and R. N. Brogden. 1995. Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria. Drugs 49:467-484. [PubMed]

63. Glass, R. I., J. Holmgren, C. E. Haley, M. R. Khan, A. M. Svennerholm, B. J. Stoll, K. M. Belayet Hossain, R. E. Black, M. Yunus, and D. Barua. 1985. Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. Am. J. Epidemiol. 121:791-796. [PubMed]

64. Gonzalez-Cortes, A., E. J. Gangarosa, C. Parrilla, W. T. Martin, A. M. Espinosa-Ayala, L. Ruiz, D. Bessudo, and H. Hernandez-Arreortua. 1982. Bottled beverages and typhoid fever: the Mexican epidemic of 1972-73. Am. J. Public Health 72:844-845. [PMC free article] [PubMed]

65. Gorbach, S. L. 1990. Bismuth therapy in gastro-intestinal diseases. Gastroenterology 99:863-875. [PubMed]

66. Gorbach, S. L. 2005. How to hit the runs for fifty million travelers at risk. Ann. Intern. Med. 142:861-862. [PubMed]

67. Gorbach, S. L., and R. Edelman. 1985. Travelers diarrhea: National Institutes of Health Consensus Conference. JAMA 253:2700-2704. [PubMed]

68. Gotuzzo, E., R. A. Oberhelman, C. Maguina, S. J. Berry, A. Yi, M. Guzman, R. Ruiz, R. Leon-Barua, and R. B. Sack. 1989. Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults. Antimicrob. Agents Chemother. 33:1101-1104. [PMC free article] [PubMed]

69. Greenberg, D. E., Z. D. Ziang, R. Steffen, M. P. Verenker, and H. L. DuPont. 2002. Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity. J. Infect. Dis. 185:944-949. [PubMed]

70. Guandalini, S., A. Fasano, M. C. Rao, A. Ferola, M. Migliavacca, G. Marchesano, and A. Rubino. 1984. Effects of loperamide on intestinal ion transport. J. Pediatr. Gastroenterol. Nutr. 3:593-601. [PubMed]

71. Guerena-Burgueno, F., E. R. Hall, D. N. Taylor, F. J. Cassels, D. A. Scott, M. K. Wolf, Z. J. Roberts, G. V. Nesterova, C. R. Alving, and G. M. Glenn. 2002. Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously. Infect. Immun. 70:1874-1880. [PMC free article] [PubMed]

72. Hall, E. R., T. F. Wierzba, C. Ahren, M. R. Rao, S. Bassily, W. Francis, F. Y. Girgis, M. Safwat, Y. J. Lee, A. M. Svennerholm, J. D. Clemens, and S. J. Savarino. 2001. Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine. Infect. Immun. 69:2853-2857. [PMC free article] [PubMed]

73. Hardie, R. M., P. G. Wall, P. Gott, M. Bardhan, and L. R. Bartlett. 1999. Infectious diarrhea in tourists staying in a resort hotel. Emerg. Infect. Dis. 5:168-171. [PMC free article] [PubMed]

74. Harris, J. B., A. I. Khan, R. C. LaRocque, D. J. Dorer, F. Chowdhury, A. S. Faruque, D. A. Sack, E. T. Ryan, F. Qadri, and S. B. Calderwood. 2005. Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect. Immun. 73:7422-7427. [PMC free article] [PubMed]

75. Henderson, I. R., J. Czeczulin, C. Eslava, F. Noriega, and J. P. Nataro. 1999. Characterization of Pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli. Infect. Immun. 67:5587-5596. [PMC free article] [PubMed]

76. Hickey, T. E., A. L. McVeigh, D. A. Scott, R. E. Michielutti, A. Bixby, S. A. Carroll, A. L. Bourgeois, and P. Guerry. 2000. Campylobacter jejuni cytolethal distending toxin mediates release of interleukin-8 from intestinal epithelial cells. Infect. Immun. 68:6535-6541. [PMC free article] [PubMed]

77. Hicks, S., D. C. Candy, and A. D. Phillips. 1996. Adhesion of enteroaggregative Escherichia coli to pediatric intestinal mucosa in vitro. Infect. Immun. 64:4751-4760. [PMC free article] [PubMed]

78. Hilton, E., P. Kolakowski, C. Singer, and M. Smith. 1997. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J. Travel Med. 1:41-43. [PubMed]

79. Hoge, C. W., J. M. Gambel, A. Srijan, C. Pitarangsi, and P. Echeverria. 1998. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin. Infect. Dis. 26:341-345. [PubMed]

80. Hoge, C. W., D. R. Shlim, P. Echeverria, R. Rajah, J. E. Herrmann, and J. H. Cross. 1996. Epidemiology of diarrhea among expatriate residents living in a highly endemic environment. JAMA 275:533-538. [PubMed]

81. Hoge, C. W., D. R. Shlim, R. Rajah, J. Triplett, M. Shear, J. G. Rabold, and P. Echeverria. 1993. Epidemiology of diarrhoeal illness associated with coccidian-like organisms among travelers and foreign residents in Nepal. Lancet 341:1175-1179. [PubMed]

82. Hohmann, E. L., C. A. Oletta, K. P. Killeen, and S. I. Miller. 1996. phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J. Infect. Dis. 173:1408-1414. [PubMed]

83. Holt, P. 1985. Severe salmonella infection in patients with reduced gastric acidity. Practitioner 229:1027-1030. [PubMed]

84. Hoover, W. W., E. H. Gerlach, D. J. Hoban, G. M. Eliopoulos, M. A. Pfaller, and R. N. Jones. 1993. Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative. Diagn. Microbiol. Infect. Dis. 16:111-118. [PubMed]

85. Huang, D. B., H. L. DuPont, Z. D. Jiang, L. Carlin, and P. C. Okhuysen. 2004. Interleukin-8 response in an intestinal HCT-8 cell line infected with enteroaggregative and enterotoxigenic Escherichia coli. Clin. Diagn. Lab. Immunol. 11:548-551. [PMC free article] [PubMed]

86. Huang, D. B., M. Awasthi, B. M. Le, M. E. Leve, M. W. DuPont, H. L. DuPont, and C. D. Ericsson. 2004. The role of diet in the treatment of travelers' diarrhea: a pilot study. Clin. Infect. Dis. 39:468-471. [PubMed]

87. Hutson, A. M., R. L. Atmar, D. Y. Graham, and M. K. Estes. 2002. Norwalk virus infection and disease is associated with ABO histo-blood group type. J. Infect. Dis. 185:1335-1337. [PubMed]

88. Infante, R. M., C. D. Ericsson, Z. D. Jiang, S. Ke, R. Steffen, L. Riopel, D. A. Sack, and H. L. DuPont. 2004. Enteroaggregative Escherichia coli diarrhea in travelers: response to rifaximin therapy. Clin. Gastroenterol. Hepatol. 2:135-138. [PubMed]

89. Jelinek, T., M. Lotze, S. Eichenlaub, T. Loscher, and H. D. Nothdurft. 1997. Prevalence of infection with Cryptosporidium parvum and Cyclospora cayetanensis among international travelers. Gut 41:801-804. [PMC free article] [PubMed]

90. Jertborn, M., C. Ahren, J. Holmgren, and A. M. Svennerholm. 1998. Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine. Vaccine 16:225-260. [PubMed]

91. Jiang, Z. D., B. Lowe, M. P. Verenkar, D. Ashley, R. Steffen, N. Tornieporth, F. von Sonnenburg, P. Waiyaki, and H. L. DuPont. 2002. Prevalence of enteric pathogens among international travlers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J. Infect. Dis. 185:497-502. [PubMed]

92. Jiang, Z. D., D. Greenberg, J. P. Nataro, R. Steffen, and H. L. Dupont. 2002. Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers. J. Clin. Microbiol. 40:4185-4190. [PMC free article] [PubMed]

93. Jiang, Z. D., P. C. Okhuysen, D. C. Guo, H. Rumin, T. M. King, H. L. DuPont, and D. M. Milewicz. 2003. Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J. Infect. Dis. 188:506-511. [PubMed]

94. Johnson, P. D., C. D. Ericsson, H. L. DuPont, D. R. Morgan, J. A. Bitsura, and L. V. Wood. 1986. Comparison of loperamide with bismuth subsalicylate for the treatment of acute traveler's diarrhea. JAMA 255:757-760. [PubMed]

95. Jokipii, L., and A. M. M. Jokipii. 1974. Giardiasis in travelers: a prospective study. J. Infect. Dis. 130:295-299. [PubMed]

96. Katz, D. E., A. J. DeLorimier, M. K. Wolf, E. R. Hall, F. J. Cassels, J. E. van Hamont, R. L. Newcomer, M. A. Davachi, D. N. Taylor, and C. E. McQueen. 2003. Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen. Vaccine 21:341-346. [PubMed]

97. Katz, D. E., T. S. Coster, M. K. Wolf, F. C. Trespalacios, D. Cohen, G. Robins, A. B. Hartman, M. M. Venkatesan, D. N. Taylor, and T. L. Hale. 2004. Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers. Infect. Immun. 72:923-930. [PMC free article] [PubMed]

98. Keystone, J. S. 1994. Single-dose antibiotic treatment for travellers' diarrhoea. Lancet 344:1520-1521. [PubMed]

99. Kirkpatrick, B. D., K. M. Tenney, C. J. Larsson, J. P. O'Neill, C. Ventrone, M. Bentley, A. Upton, Z. Hindle, C. Fidler, D. Kutzko, R. Holdridge, C. Lapointe, S. Hamlet, and S. N. Chatfield. 2005. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations. J. Infect. Dis. 192:360-366. [PubMed]

100. Kollaritsch, H. 1989. Travelers' diarrhea among Austrian tourists in warm climate countries. I. Epidemiology. Eur. J. Epidemiol. 5:74-81. [PubMed]

101. Kossaczka, Z., F. Y. Lin, V. A. Ho, N. T. Thuy, P. Van Bay, T. C. Thanh, H. B. Khiem, D. D. Trach, A. Karpas, S. Hunt, D. A. Bryla, R. Schneerson, J. B. Robbins, and S. C. Szu. 1999. Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam. Infect. Immun. 67:5806-5810. [PMC free article] [PubMed]

102. Kotloff, K. L., D. N. Taylor, M. B. Sztein, S. S. Wasserman, G. A. Losonsky, J. P. Nataro, M. Venkatesan, A. Hartman, W. D. Picking, D. E. Katz, J. D. Campbell, M. M. Levine, and T. L. Hale. 2002. Phase I evaluation of ΔvirG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults. Infect. Immun. 70:2016-2021. [PMC free article] [PubMed]

103. Kozicki, M., R. Steffen, and M. Schar. 1985. “Boil it, cook it, peel it, or forget it”: does this rule prevent travellers' diarrhoea? Int. J. Epidemiol. 14:169-172. [PubMed]

104. Kuschner, R. A., A. F. Trofa, R. J. Thomas, C. W. Hoge, C. Pitarangsi, S. Amato, R. P. Olafson, P. Echeverria, J. C. Sadoff, and D. N. Taylor. 1995. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin. Infect. Dis. 21:536-541. [PubMed]

105. Levine, M. M., D. R. Nalin, M. B. Rennels, R. B. Hornick, S. Sotman, G. Van Blerk, T. P. Hughes, S. O'Donnell, and D. Barua. 1979. Genetic susceptibility to cholera. Ann. Hum. Biol. 6:369-374. [PubMed]

106. Lin, F. Y., V. A. Ho, H. B. Khiem, D. D. Trach, P. V. Bay, T. C. Thanh, Z. Kossaczka, D. A. Bryla, J. Shiloach, J. B. Robbins, R. Schneerson, and S. C. Szu. 2001. The efficacy of a Salmonella typhi Vi conjugate vaccine in two- to five-year-old children. N. Engl. J. Med. 344:1263-1269. [PubMed]

107. Lindesmith, L., C. Moe, S. Marionneau, N. Ruvoen, X. Jiang, L. Lindblad, P. Stewart, J. LePendu, and R. Baric. 2003. Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 9:548-553. [PubMed]

108. Liu, L. X. 1993. Travel medicine part II: malaria, traveler's diarrhea, and other problems. Infect. Med. 10:24-28.

109. Mai, N. L., V. B. Phan, A. H. Vo, C. T. Tran, F. Y. Lin, D. A. Bryla, C. Chu, J. Schiloach, J. B. Robbins, R. Schneerson, and S. C. Szu. 2003. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children. N. Engl. J. Med. 349:1390-1391. [PubMed]

110. Manhart, M. D. 1990. In vitro activity of bismuth subsalicylate and other bismuth salts. Rev. Infect. Dis. 12:S11-S15. [PubMed]

111. Mattila, L., A. Siitonen, H. Kyronseppa, I. I. Simula, and H. Peltola. 1995. Risk behavior for travelers' diarrhea among Finnish travelers. J. Travel Med. 2:77-84. [PubMed]

112. Mattila, L., A. Siitonen, H. Kyronseppa, I. Simula, P. Oksanen, M. Stenvik, P. Salo, and H. Peltola. 1992. Seasonal variation in etiology of travelers' diarrhea. J. Infect. Dis. 165:385-388. [PubMed]

113. Mattila, L., H. Peltola, A. Siitonen, H. Kyronseppa, I. Simula, and M. Kataja. 1993. Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons. Clin. Infect. Dis. 17:779-782. [PubMed]

114. McConnell, M. M., M. L. Hibberd, M. E. Penny, S. M. Scotland, T. Cheasty, and B. Rowe. 1991. Surveys of human enterotoxigenic Escherichia coli from three different geographical areas for possible colonization factors. Epidemiol. Infect. 106:477-484. [PMC free article] [PubMed]

115. McDonald-Gibson, W. J., and H. O. J. Collier. 1984. Inhibition of arachidonate and Escherichia coli-induced enteropooling in the rat by acetylsalicylic acid and similar drugs. Prostaglandins 28:731-737.

116. Nataro, J. P., D. Yikang, J. A. Giron, S. J. Savarino, M. H. Kothary, and R. Hall. 1993. Aggregative adherence fimbria I expression in enteroaggregative Escherichia coli requires two unlinked plasmid regions. Infect. Immun. 61:1126-1131. [PMC free article] [PubMed]

117. Nataro, J. P., T. Steiner, and R. L. Guerrant. 1998. Enteroaggregative Escherichia coli. Emerg. Infect. Dis. 4:251-261. [PMC free article] [PubMed]

118. Nataro, J. P., Y. Deng, D. R. Maneval, A. L. German, W. C. Martin, and M. M. Levine. 1992. Aggregative adherence fimbriae I of enteroaggregative Escherichia coli mediate adherence to HEp-2 cells and hemagglutination of human erythrocytes. Infect. Immun. 60:2297-2304. [PMC free article] [PubMed]

119. Navarro-Garcia, F., C. Eslava, J. M. Villaseca, R. Lopez-Revilla, J. R. Czeczulin, S. Srinivas, J. P. Nataro, and A. Cravioto. 1998. In vitro effects of a high-molecular-weight heat-labile enterotoxin from enteroaggregative Escherichia coli. Infect. Immun. 66:3149-3154. [PMC free article] [PubMed]

120. Navarro-Garcia, F., C. Sears, C. Eslava, A. Cravioto, and J. P. Nataro. 1999. Cytoskeletal effects induced by Pet, the serine protease enterotoxin of enteroaggregative Escherichia coli. Infect. Immun. 67:2184-2192. [PMC free article] [PubMed]

121. Neal. K. R., H. M. Scott, R. C. Slack, and R. F. Logan. 1998. Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study. BMJ 312:414-415. [PMC free article] [PubMed]

122. Okhuysen, P. C., and C. D. Ericsson. 1992. Travelers' diarrhea prevention and treatment. Med. Clin. N. Am. 76:1357-1373. [PubMed]

123. Okhuysen, P. C., Z. D. Jiang, L. Carlin, C. Forbes, and H. L. DuPont. 2004. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am. J. Gastroenterol. 99:1774-1778. [PubMed]

124. Oksanen, P. J., S. Salminen, M. Saxelin, P. Hamelainen, A. Ihantola-Vormisto, L. Muurasniemi-Isoviita, S. Nikkari, T. Oksanen, I. Porsti, E. Salminen, et al. 1990. Prevention of travelers' diarrhea by Lactobacillus GG. Ann. Med. 22:53-56. [PubMed]

125. Orr, N., D. E. Katz, J. Atsmon, P. Radu, M. Yavzori, T. Halperin, T. Sela, R. Kayouf, Z. Klein, R. Ambar, D. Cohen, M. K. Wolf, M. M. Venkatesan, and T. L. Hale. 2005. Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers. Infect. Immun. 73:8027-8032. [PMC free article] [PubMed]

126. Peltola, H., and S. L. Gorbach. 1997. Travelers' diarrhea epidemiology and clinical aspects, p. 78-86. In H. L. DuPont and R. Steffen (ed.), Textbook of travel medicine and health. BC Decker Inc., Hamilton, Canada.

127. Peltola, H., A. Siitonen, H. Kyronseppa, I. Simula, L. Mattila, P. Oksanen, M. J. Kataja, and M. Cadoz. 1991. Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet 338:1285-1289. [PubMed]

128. Peltola, H., H. Kyronseppa, and P. Holsa. 1983. Trips to the South—a health hazard: morbidity of Finnish travelers. Scand. J. Infect. Dis. 15:375-381. [PubMed]

129. Pitzinger, B., R. Steffen, and A. Tschopp. 1991. Incidence and clinical features of traveler's diarrhea in infants and children. Pediatr. Infect. Dis. J. 10:719-723. [PubMed]

130. Qadri, F., A.-M. Svennerholm, A. S. G. Faruque, and R. B. Sack. 2005. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin. Microbiol. Rev. 18:465-483. [PMC free article] [PubMed]

131. Qadri, F., S. K. Das, A. S. Faruque, G. J. Fuchs, M. J. Albert, R. B. Sack, and A. M. Svennerholm. 2000. Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh. J. Clin. Microbiol. 38:27-31. [PMC free article] [PubMed]

132. Qadri, F., T. Ahmed, F. Ahmed, R. Bradley Sack, D. A. Sack, and A. M. Svennerholm. 2003. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18-36 months of age. Vaccine 21:2394-2403. [PubMed]

133. Qadri, F., T. Ahmed, F. Ahmed, Y. A. Begum, D. A. Sack, and A. M. Svennerholm. 2006. Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is [sic] safe and immunogenic in Bangladeshi infants 6-17 months of age: dosing studies in different age groups. Vaccine 24:1726-1733. [PubMed]

134. Rademaker, C. M., I. M. Hoepelman, M. J. Wolfhagen, H. Beumer, M. Rozenberg-Arska, and J. Verhoef. 1989. Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers diarrhea. Eur. J. Clin. Microbiol. Infect. Dis. 8:690-694. [PubMed]

135. Reinthaler, F. F., G. Feierl, D. Stunzner, and E. Marth. 1998. Diarrhea in returning Austrian tourists: epidemiology, etiology, and cost-analyses. J. Travel Med. 5:65-72. [PubMed]

136. Reves, R. R., P. C. Johnson, C. D. Ericsson, and H. L. DuPont. 1988. A cost-effectiveness comparison of the use of antimicrobial agents for treatment or prophylaxis of travelers' diarrhea. Arch. Intern. Med. 148:2421-2427. [PubMed]

137. Rose, F. C., and M. Gawel. 1984. Clioquinol neurotoxicity: an overview. Acta Neurol. Scand. 70(Suppl. 100):137-145. [PubMed]

138. Sack, D. A., D. C. Kaminsky, R. B. Sack, J. N. Itotia, R. R. Arthur, A. Z. Kapikian, F. Orskov, and I. Orskov. 1978. Prophylactic doxycycline for travelers' diarrhea: results of a prospective double-blind study of Peace Corps volunteers in Kenya. N. Engl. J. Med. 298:758-763. [PubMed]

139. Sack, D. A., J. Shimko, O. Torres, A. Karnell, I. Nyquist, B. Gustafsson, A. L. Bourgeois, O. Newton, and A. Svennerholm. 2002. Presented at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, Calif.

140. Salam, I., P. Katelaris, S. Leigh-Smith, and M. J. Farthing. 1994. Randomised trial of single-dose ciprofloxacin for travellers' diarrhoea. Lancet 344:1537-1539. [PubMed]

141. Sanchez, J. L., J. Gelnett, B. P. Petruccelli, R. F. Defraites, and D. N. Taylor. 1998. Diarrheal disease incidence and morbidity among United States personnel during short-term missions overseas. Am. J. Trop. Med. Hyg. 58:299-304. [PubMed]

142. Santosham, M., R. B. Sack, J. Froehlich, H. Greenberg, R. Yolken, A. Kapikian, C. Javier, C. Medina, F. Orskov, and I. Orskov. 1981. Bi-weekly prophylactic doxycycline for travelers' diarrhea. J. Infect. Dis. 143:598-602. [PubMed]

143. Scarpignato, C., and P. Rampal. 1995. Prevention and treatment of traveler's diarrhea: a clinical pharmacological approach. Chemotherapy 41:48-81. [PubMed]

144. Schlim, D. R. 2006. Looking for evidence that personal hygiene precautions prevent traveler's diarrhea. Clin. Infect. Dis. 41:S521-S586. [PubMed]

145. Scott, D. A. 1997. Vaccines against Campylobacter jejuni. J. Infect. Dis. 176:S183-S188. [PubMed]

146. Shaheen, H. I., K. A. Kamal, M. O. Wasfy, N. M. El-Ghorab, B. Lower, R. Steffen, N. Kodkani, L. Amsler, P. Waiyaki, J. C. David, S. B. Khalil, and L. F. Peruski, Jr. 2003. Phenotypic diversity of enterotoxigenic Escherichia coli (ETEC) isolated from cases of travelers' diarrhea in Kenya. Int. J. Infect. Dis. 7:35-38. [PubMed]

147. Shane, A. L., T. H. Roels, M. Goldoft, H. Herikstad, and F. J. Angulo. 2002. Foodborne disease in our global village: a multinational investigation of an outbreak of Salmonella serotype Enteritidis phage type 4 infection in Puerto Vallarta, Mexico. Int. J. Infect. Dis. 6:98-102. [PubMed]

148. Shigematsu, M., M. E. Kaufmann, A. Charlett, Y. Niho, and T. L. Pitt. 2000. An epidemiological study of Plesiomonas shigelloides diarrhoea among Japanese travellers. Epidemiol. Infect. 125:523-530. [PMC free article] [PubMed]

149. Smallman-Raynor, M. R., and A. D. Cliff. 2004. Impact of infectious diseases on war. Infect. Dis. Clin. N. Am. 18:341-368. [PubMed]

150. Spangler, B. D. 1992. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56:622-647. [PMC free article] [PubMed]

151. Sriratanaban, A., and S. Reinprayoon. 1982. Vibrio parahaemolyticus: a major cause of travelers' diarrhea in Bangkok. Am. J. Trop. Med. Hyg. 31:128-130. [PubMed]

152. Steffen, R. 1986. Epidemiologic studies of travelers' diarrhea, severe gastrointestinal infection and cholera. Rev. Infect. Dis. 8:S122-S130. [PubMed]

153. Steffen, R., D. A. Sack, L. Riopel, Z. D. Jiang, M. Sturchler, C. D. Ericsson, B. Lowe, P. Waiyaki, M. White, and H. L. DuPont. 2003. Therapy of travelers' diarrhea with rifaximin on various continents. Am. J. Gastroenterol. 98:1073-1078. [PubMed]

154. Steffen, R., F. Collard, N. Tornieporth, S. Campbell-Forrester, D. Ashley, S. Thompson, J. J. Mathewson, E. Maes, B. Stephenson, H. L. DuPont, and F. von Sonnenburg. 1999. Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica. JAMA 281:811-817. [PubMed]

155. Steffen, R., F. Van Der Linde, K. Gyr, and M. Schar. 1983. Epidemiology of diarrhea in travelers. JAMA 249:1176-1180. [PubMed]

156. Steffen, R., H. L. DuPont, R. Heusser, A. Helminger, F. Witassek, M. D. Manhart, and M. Schar. 1986. Prevention of traveler's diarrhea by the tablet form of bismuth subsalicylate. Antimicrob. Agents Chemother. 29:625-627. [PMC free article] [PubMed]

157. Steffen, R., R. Jori, H. L. DuPont, J. J. Mathewson, and D. Sturchler. 1993. Efficacy and toxicity of fleroxacin in the treatment of traveler's diarrhea. Am. J. Med. 94:182S-186S. [PubMed]

158. Suh, K. N., and J. S. Keystone. 2004. Antibiotics for travelers: what's good and what's not. Curr. Infect. Dis. Rep. 6:13-21. [PubMed]

159. Svennerholm, A. M., and S. J. Savarino. 2004. Oral inactivated whole cell B subunit combination vaccine against enterotoxigenic Escherichia coli, 3rd ed. Marcel Dekker, New York, N.Y.

160. Szu, S. C., D. N. Taylor, A. C. Trofa, J. D. Clements, J. Shiloach, J. C. Sadoff, D. A. Bryla, and J. B. Robbins. 1994. Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines. Infect. Immun. 62:4440-4444. [PMC free article] [PubMed]

161. Tacket, C. O., M. B. Cohen, and S. S. Wasserman. 1999. Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El Tor Inaba three months after vaccination. Infect. Immun. 67:6341-6345. [PMC free article] [PubMed]

162. Tacket, C. O., M. B. Sztein, S. S. Wasserman, G. Losonsky, K. L. Kotloff, T. L. Wyant, J. P. Nataro, R. Edelman, J. Perry, P. Bedford, D. Brown, S. Chatfield, G. Dougan, and M. M. Levine. 2000. Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers. Infect. Immun. 68:1196-1201. [PMC free article] [PubMed]

163. Tacket, C. O., M. F. Pasetti, M. B. Sztein, S. Livio, and M. M. Levine. 2004. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide. J. Infect. Dis. 190:565-570. [PubMed]

164. Taylor, D. N., A. C. Trofa, J. Sadoff, C. Chu, D. Bryla, J. Shiloach, D. Cohen, S. Ashkenazi, Y. Lerman, W. Egan, R. Schneerson, and J. B. Robbins. 1993. Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids. Infect. Immun. 61:3678-3687. [PMC free article] [PubMed]

165. Taylor, D. N., J. L. Sanchez, W. Candler, S. Thornton, C. McQueen, cipro and P. Echeverria. 1991. Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial. Ann. Intern. Med. 113:731-734. [PubMed]

166. Tjoa, W. S., H. L. DuPont, P. Sullivan, L. K. Pickering, A. H. Holguin, J. Olarte, D. G. Evans, and D. J. Evans, Jr. 1977. Location of food consumption and travelers' diarrhea. Am. J. Epidemiol. 106:61-66. [PubMed]

167. Turner, A. K., T. D. Terry, D. A. Sack, P. Londono-Arcila, and M. J. Darsley. 2001. Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans. Infect. Immun. 69:4969-4979. [PMC free article] [PubMed]

168. United Nations World Tourism Organization. 2005. Tourism highlights: 2005 edition. United Nations World Tourism Organization, Madrid, Spain.

169. Van Loon, F. P. L., M. L. Bennish, P. Speelman, and C. Butler. 1989. Double blind trial of loperamide for treating acute watery diarrhoea in expatriates in Bangladesh. Gut 30:492-495. [PMC free article] [PubMed]

170. Vila, J., J. Ruiz, F. Gallardo, M. Vargas, L. Soler, M. J. Figueras, and J. Gascon. 2003. Aeromonas spp. and traveler's diarrhea: clinical features and antimicrobial resistance. Emerg. Infect. Dis. 9:552-555. [PMC free article] [PubMed]

171. Villaseca, J. M., F. Navarro-Garcia, G. Mendoza-Hernandez, J. P. Nataro, A. Cravioto, and C. Eslava. 2000. Pet toxin from enteroaggregative Escherichia coli produces cellular damage associated with fodrin disruption. Infect. Immun. 68:5920-5927. [PMC free article] [PubMed]

172. Wagner, A. R., B. E. Murray, P. Echeverria, J. J. Mathewson, and H. L. Dupont. 1988. Enteroinvasive Escherichia coli in travelers with diarrhea. J. Infect. Dis. 158:640-642. [PubMed]

173. Yamada, S., S. Matsushita, S. Dejsirilert, and Y. Kudoh. 1997. Incidence and clinical symptoms of Aeromonas-associated travellers' diarrhoea in Tokyo. Epidemiol. Infect. 119:121-126. [PMC free article] [PubMed]


BUY NOW For Sale 70%!
buy viagra

Travelers Diarrhea Management - Family Practice Notebook Staphylococcus coagulase negative ciprofloxacin

Cipro dose for travelers diarrhea Travelers Diarrhea - Chapter Yellow Book Travelers
Cipro dose for travelers diarrhea Ciprofloxacin Dosage Guide with Precautions - m
Cipro dose for travelers diarrhea Travellers Diarrhoea - Fit For Travel
Cipro dose for travelers diarrhea Traveler s Diarrhea
Cipro dose for travelers diarrhea # How To Naturally Detox Your Body From Cipro - How
Cipro dose for travelers diarrhea (erythromycin ophthalmic) dosing, indications
Behandlung: Atemwegserkrankungen mit Verschleimung CIPRO IS POISON! Cached Cipro (Ciprofloxacin Side Effects, Interactions, Warning) How Much Fluoride Is In Fluoride Gel and Other Dental
BUY NOW For Sale 70%!
buy viagra